Company / Accounts Receivable
Cooper Companies (The) Accounts Receivable History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$829.0M
FY2025
5-year range
$515.3M / $829.0M
FY2021-FY2025
Trend
+15.6%
vs FY2024
Sector context
#31 of 143
Health Care
What the data says
Cooper Companies (The)'s accounts receivable of $829M is higher than 78% of companies in the Health Care sector (FY2025). Accounts Receivable has increased for 9 consecutive years, from $291M in FY2016 to $829M in FY2025.
Based on SEC 10-K filings.
$829M in FY2025 with a 5-year CAGR of +13.7%. Top quartile in the Health Care sector.
Improved from $610M to $829M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +14.1%
- 5-Year CAGR
- +13.7%
- 10-Year CAGR
- -
Sector benchmark
-37.7% below sector average
Key checks
Key Insights
- Cooper Companies (The)'s accounts receivable has grown for 9 consecutive years.
- 5-year CAGR of +13.7%, indicating consistent growth.
- In FY2025, accounts receivable increased 15.6% year-over-year.
- Ranks #31 out of 143 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $829.0M | +15.6% |
| FY2024 | $717.0M | +17.6% |
| FY2023 | $609.7M | +9.3% |
| FY2022 | $557.8M | +8.2% |
| FY2021 | $515.3M | +18.4% |
| FY2020 | $435.4M | +0.0% |
| FY2019 | $435.3M | +16.2% |
| FY2018 | $374.7M | +18.4% |
| FY2017 | $316.6M | +8.6% |
| FY2016 | $291.4M | +3.0% |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026